Paul Miranda, MD

Board-Certified in Family Medicine · Emergency Physician · Obesity Medicine Association member

I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.

Medically reviewed by Paul Miranda, MD

If you typed “how do I get semaglutide prescribed” into Google from Chattanooga, you’ve probably already landed on three intake forms that promise next-day shipping. None of them answer the actual question. Getting semaglutide prescribed isn’t a shipping problem — it’s a clinical decision about whether you’re a candidate, what your starting dose should be, and who is watching you titrate up. I’m Paul Miranda, a board-certified physician practicing telehealth from right here in Chattanooga, and I personally review every chart before a patient at Summit Metabolic Health gets a prescription. Here’s what that evaluation actually involves.

Candidacy isn’t a yes/no toggle on a form. The FDA labeling and the clinical guidelines behind it set the baseline: a BMI of 30 or higher, or 27 or higher with a weight-related condition like hypertension, type 2 diabetes, high cholesterol, or sleep apnea. That’s the floor, not the whole decision.

The physician evaluation goes further, because the questions that actually determine safety aren’t on a checkbox form. Personal or family history of medullary thyroid cancer or MEN2 syndrome is a hard contraindication. A history of pancreatitis, active gallbladder disease, or a GI motility disorder changes the plan. Current medications matter — insulin and sulfonylureas need dose adjustments to avoid hypoglycemia once semaglutide is added. Pregnancy status matters. None of this is answered by a symptom checklist you fill out yourself. It’s answered by a physician reading your actual history and deciding, case by case, what’s safe for you specifically — including how fast, or how slowly, your dose should move. (If you want the fuller breakdown of who qualifies and who doesn’t, I wrote a dedicated guide on GLP-1 candidacy criteria for Chattanooga patients.)

There’s also a question candidacy alone doesn’t answer: how fast should your dose actually climb once you’re approved? The manufacturer’s label sets the fastest allowed schedule, not the right one for every patient. At Summit, dose escalation is deliberately paced — the goal is to spend the maximum time at the lowest dose that’s working, with a scheduled hold roughly every 25 pounds lost, rather than climbing the ladder as fast as the label permits. That pacing decision is part of the same evaluation as the candidacy check. It’s not a separate step you negotiate later.

The reason this evaluation matters is the same reason the drug works: the trial data describes a monitored process, not a one-time transaction. In STEP 1, semaglutide 2.4mg produced 14.9% mean weight loss at 68 weeks, against 2.6% on placebo (Wilding et al., NEJM, 2021). That’s a real, well-replicated number — and it’s a group average from patients who were titrated up gradually and followed the whole time, not a promise about what happens the week your dose arrives in the mail.

The SELECT trial added something more consequential than the weight-loss number: in patients with established cardiovascular disease, semaglutide reduced major adverse cardiovascular events — heart attack, stroke, cardiovascular death — by 20% (Lincoln et al., NEJM, 2023). That finding is why I don’t treat this as a cosmetic prescription. I work ER shifts. I see what untreated cardiovascular risk looks like when it finally shows up. A medication with a 20% MACE reduction in the right patient is a cardiovascular intervention, and it deserves a physician tracking your blood pressure, your labs, and your tolerance the same way any other cardiovascular medication would get tracked — not a one-time questionnaire that never checks back in.

This is exactly where the query “how do I get semaglutide prescribed” gets answered two different ways online. Ro, Hims/Hers, and Henry Meds convert this search through async questionnaires — you answer some questions, and a prescription gets generated without a confirmed physician evaluating your case the way a chart review requires. The internet has made GLP-1 medications easy to get. A few clicks, a form, and a vial shows up. But “easy to get” and “well managed” are not the same thing, and for a medication this powerful, the gap matters.

A checkbox you click yourself is not the same as a physician reviewing your actual history, deciding your starting dose, and adjusting it based on how you actually respond. That’s the entire reason I read every chart myself. I’ve written more on how to tell the difference between a real physician-led telehealth practice and a form that just looks like one in what actually makes telehealth semaglutide legitimate.

There’s a practical test for this, and you can run it yourself before you sign up anywhere: ask who reviews your case if your side effects are worse than expected at week three. On a questionnaire-run platform, the honest answer is usually a queue, a message thread, or a different clinician than the one who wrote your first prescription. At Summit, it’s me — the same physician who set your starting dose is the one adjusting it, every time.

Here’s what actually happens, start to finish:

1. You apply. A short intake — not a diagnostic form, just enough for me to start reviewing your case. 2. I review your chart personally. Your history, current medications, comorbidities, and any contraindications get read by me before you’re scheduled — not triaged by software. 3. You get a live physician evaluation. We go through candidacy, your goals, and what a realistic titration plan looks like for you. 4. Your starting dose is set individually. Not the manufacturer’s fastest label-allowed schedule by default — a pace matched to your tolerance. 5. You’re followed through titration. Dose increases happen when you’re ready for them, not on a fixed calendar, and side effects get managed by the physician who set the dose, not a call center. 6. We plan the exit before we start. Maintenance and eventual taper get discussed from day one, not improvised later.

The DTC telehealth funnels advertise an intro rate, then step the price up once you’re locked in. Hims/Hers runs $448–548 a month after the introductory period. Ro runs $349–498 a month. Neither number is on the landing page you first see.

Summit’s pricing is $135–225 a month, and it’s the number from day one — not an intro rate that doubles at month three. I’ve broken down exactly what that buys, and how it compares dollar-for-dollar to the national platforms, in the real cost of semaglutide without insurance in Chattanooga. The goal is your long-term result, not your long-term billing.

Getting semaglutide prescribed the right way means a physician looked at your specific history before your dose was decided, and stays involved while it’s adjusted. That’s not a national call center reading a script. It’s a board-certified physician, based in this city, who reads your chart, sets your starting dose, and manages your titration personally.

If you want to see more of how Summit approaches GLP-1 care and what else patients in Chattanooga are asking, the Summit Metabolic Health blog has the rest of it.

Ready to start? Apply at summitmetabolichealth.com/apply.

This post is educational and doesn’t replace an individual medical evaluation. Semaglutide isn’t right for everyone — candidacy is determined during your physician evaluation.